Skip to main content

Venture

OrbiMed Banks $3 billion for Two Healthcare venture funds

Thursday, October 15, 2026 · first reported by WSJ and 12 others

OrbiMed has raised $3 billion across two new funds, according to several outlets. AltAssets reports that one is a US and European life sciences fund and the other is the manager's sixth Asian healthcare investment vehicle, which passed $1 billion for the first time. Dealroom puts the life sciences fund at $1.9 billion within the $3 billion double close.

Outlets differ on how to label the vehicles. Law360 and PR Newswire call them private equity funds, while WSJ calls them venture funds. PR Newswire describes them as global and Asia funds.

Size
$3B
Stage
Raising
Asset class
Venture
Geography
Global

In the data This close in the fund closes table · Every OrbiMed close

Terms Growth equity · Private equity · Venture capital

The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.

See an error?

Get every venture capital fundraise like this one in FundOps Daily. Free, every morning by 7:30am ET.

Read each morning at 190+ firms: GPs, LPs, and fund service providers. See a sample edition

Coverage

13 sources
All 13 outlets

More in Venture capital

From the same day

Got news? Send it to us →